Teradyne, Inc (NYSE: TER) reported revenue of $121 million for the first
quarter of 2009. On a non-GAAP basis, Teradyne’s net loss in the first
quarter was $65.6 million, or $0.38 per diluted share, which excludes
restructuring charges, acquired intangible asset amortization and
special items. The GAAP net loss for the first quarter was $90.7
million, or $0.53 per diluted share.
Bookings for the first quarter were $136 million, including $31 million
for Hard Disk Drive test systems.
Guidance for the second quarter of 2009 is for revenue of $120 million
to $130 million, with a loss per share between $0.26 and $0.23 on a
non-GAAP basis and between $0.44 and $0.40 on a GAAP basis. Non-GAAP
guidance excludes restructuring charges, as well as acquired intangible
asset amortization, and other special items.
"Despite a very harsh business climate in the first quarter, we’re
beginning to see some initial recovery signs as we enter the second
quarter,” said Mike Bradley, Teradyne president and CEO. "Installed
equipment utilization rates are starting to turn up and customers are
formulating modest capex outlays for new IC products they’re bringing to
market in the second half of the year.
"We continue to press forward on the new product front in both our
Semiconductor Test and Systems Test markets. In the Hard Disk Drive
segment, we’ve received initial orders for our Neptune tester, and we’re
projecting revenue recognition in the third quarter. We also have very
strong operating leverage in our business model as we grow revenues
going forward.”
Webcast
A webcast to discuss first quarter 2009 results, along with management's
business outlook will be held at 10 a.m. EDT, Thursday, April 30, 2009.
Interested investors should access the webcast at www.teradyne.com
and click on "Investors" at least five minutes before the call begins.
The webcast replay will be available on www.teradyne.com.
In addition, a conference call replay will be available approximately
two hours after the call. The replay number in the U.S. & Canada is
800-642-1687. The replay number outside the U.S. & Canada is
706-645-9291. The pass code for both numbers is 95502319.
The
replay will be available via phone and web site through May 14, 2009.
Non-GAAP Results
In addition to disclosing results that are determined in accordance with
GAAP, Teradyne also discloses non-GAAP results of operations that
exclude certain income items and charges. These results are provided as
a complement to results provided in accordance with GAAP. Teradyne
reports non-GAAP results in order to better assess and reflect operating
performance. Management believes the non-GAAP measures help indicate
Teradyne's baseline performance before gains, losses or other charges
that may not be indicative of our current core business or future
outlook. Teradyne believes these non-GAAP measures will aid investors'
overall understanding of its results by providing a higher degree of
transparency for certain expenses and providing a level of disclosure
that will help investors understand how Teradyne plans and measures its
own business. A reconciliation of each available GAAP to non-GAAP
financial measure discussed in this press release is contained in the
attached exhibits and on the Teradyne website at www.teradyne.com
by clicking on "Investors" and then selecting the "GAAP to Non-GAAP
Reconciliation" link. The presentation of non-GAAP measures is not meant
to be considered in isolation, as a substitute for, or superior to,
financial measures or information provided in accordance with GAAP.
About Teradyne, Inc.
Teradyne (NYSE:TER) is a leading supplier of Automatic Test Equipment
used to test complex electronics used in the consumer electronics,
automotive, computing, telecommunications, and aerospace and defense
industries. In 2008, Teradyne had sales of $1.1 billion. For more
information, visit www.teradyne.com.
Teradyne(R) is a registered trademark of Teradyne, Inc. in
the U.S. and other countries. All product names are trademarks of
Teradyne, Inc. (including its subsidiaries) or their respective owners.
Safe Harbor Statement
The forward-looking statements included in this release are made only as
of the date of publication. Teradyne disclaims any intention or
obligation to update any forward-looking statements as a result of
developments occurring after the date of this press release.
This release contains forward-looking statements regarding future
business prospects, our results of operations and market conditions.
Such statements are based on the current assumptions and expectations of
Teradyne’s management and are neither promises nor guarantees of future
performance. You can identify these forward-looking statements based on
the context of the statements and by the fact that they use words such
as "will,” "anticipate,” "expect,” "project,” "intend,” "plan,”
"believe,” "target” and other words and terms of similar meaning in
connection with any discussion of future operating or financial
performance. There can be no assurance that management’s estimates of
our future results or other forward looking statements will be achieved.
Important factors that could cause actual results to differ materially
from those presently expected include: conditions affecting the markets
in which Teradyne operates, including a continued or further
deterioration of the semiconductor equipment market; decreased product
demand; delays in new product introductions; lack of customer acceptance
of new products; unanticipated delays in or costs and expenses relating
to the implementation of cost reduction plans; and other events, factors
and risks disclosed in filings with the SEC, including, but not limited
to, the "Risk Factors” section of Teradyne’s annual report on Form 10-K
for the fiscal year ended December 31, 2008.
|
TERADYNE, INC. REPORT FOR FIRST FISCAL QUARTER OF 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONDENSED CONSOLIDATED OPERATING STATEMENTS
|
|
(In thousands, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended:
|
|
|
|
|
|
|
|
April 5, 2009
|
|
December 31, 2008
|
|
March 30, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Revenues (1)
|
|
|
|
$
|
120,608
|
|
|
$
|
194,767
|
|
|
$
|
297,315
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of Revenues (2) (3)
|
|
|
|
|
87,248
|
|
|
|
116,856
|
|
|
|
158,812
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit
|
|
|
|
|
33,360
|
|
|
|
77,911
|
|
|
|
138,503
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Expenses:
|
|
|
|
|
|
|
|
|
|
Engineering and Development
|
|
|
|
|
47,198
|
|
|
|
52,189
|
|
|
|
55,149
|
|
Selling and Administrative
|
|
|
|
|
55,373
|
|
|
|
58,491
|
|
|
|
65,221
|
|
Acquired Intangible Asset Amortization
|
|
|
|
|
8,239
|
|
|
|
6,962
|
|
|
|
3,863
|
|
In-process Research and Development
|
|
|
|
|
-
|
|
|
|
500
|
|
|
|
1,100
|
|
Goodwill Impairment (4)
|
|
|
|
|
-
|
|
|
|
333,281
|
|
|
|
-
|
|
Restructuring and Other, net (5)
|
|
|
|
|
15,965
|
|
|
|
9,675
|
|
|
|
11,785
|
|
Operating Expenses
|
|
|
|
|
126,775
|
|
|
|
461,098
|
|
|
|
137,118
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss)/Income from Operations
|
|
|
|
|
(93,415
|
)
|
|
|
(383,187
|
)
|
|
|
1,385
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest & Other (6)
|
|
|
|
|
(5,053
|
)
|
|
|
(6,096
|
)
|
|
|
5,082
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss)/Income Before Income Taxes
|
|
|
|
|
(98,468
|
)
|
|
|
(389,283
|
)
|
|
|
6,467
|
|
Income Tax (Benefit)/Provision
|
|
|
|
|
(7,800
|
)
|
|
|
(693
|
)
|
|
|
4,100
|
|
Net (Loss)/Income
|
|
|
|
|
(90,668
|
)
|
|
|
(388,590
|
)
|
|
|
2,367
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (Loss)/Income per Common Share:
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
$
|
(0.53
|
)
|
|
$
|
(2.30
|
)
|
|
$
|
0.01
|
|
Diluted
|
|
|
|
$
|
(0.53
|
)
|
|
$
|
(2.30
|
)
|
|
$
|
0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average Common Shares - Basic
|
|
|
|
|
172,130
|
|
|
|
169,197
|
|
|
|
173,762
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average Common Shares - Diluted
|
|
|
|
|
172,130
|
|
|
|
169,197
|
|
|
|
175,722
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Orders
|
|
|
|
$
|
136,346
|
|
|
$
|
169,404
|
|
|
$
|
321,055
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) For the quarters ended December 31, 2008 and March 30, 2008, Net
Revenues excluded $3.0 million and $4.0 million, respectively, of
revenues that would otherwise be recognized except for purchase
accounting effects on acquired deferred revenue.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) For the quarters ended April 5, 2009, December 31, 2008 and
March 30, 2008, Cost of Revenues included an added cost of $1.2
million, $0.7 million and $4.3 million, respectively, for inventory
step-up as a result of purchase accounting. For the quarters ended
December 31, 2008 and March 30, 2008, Cost of Revenues included
credits of $1.0 million and $0.9 million, respectively, related to
previously written down inventory in the Semiconductor Test Division.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3) For the quarters ended April 5, 2009, December 31, 2008 and
March 30, 2008, Cost of Revenues included a provision for excess and
obsolete inventory of $8.6 million, $4.4 million and $1.3 million,
respectively.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4) Impairment of goodwill due to a sharp decline in the demand
outlook that is not expected to recover in the near term.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5) Restructuring and other, net consists of:
|
|
|
|
Quarter Ended:
|
|
|
|
|
|
|
|
April 5, 2009
|
|
December 31, 2008
|
|
March 30, 2008
|
|
Employee Severance
|
|
|
|
$
|
16,678
|
|
|
$
|
8,853
|
|
|
$
|
7,113
|
|
Eagle Test Purchase Accounting Adjustment
|
|
|
|
|
(713
|
)
|
|
|
-
|
|
|
|
-
|
|
Acquisition Financing Costs
|
|
|
|
|
-
|
|
|
|
822
|
|
|
|
-
|
|
Facility Related
|
|
|
|
|
-
|
|
|
|
-
|
|
|
|
4,672
|
|
|
|
|
|
|
|
$
|
15,965
|
|
|
$
|
9,675
|
|
|
$
|
11,785
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6) For the quarters ended April 5, 2009 and December 31, 2008,
Interest and Other included charges of $2.6 million and $7.2
million, respectively, for other-than-temporary impairment and
realized losses on marketable securities.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April 5, 2009
|
|
December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
Cash and Cash Equivalents
|
|
|
|
|
|
$
|
279,057
|
|
|
$
|
322,705
|
|
Accounts Receivable
|
|
|
|
|
|
|
67,259
|
|
|
|
109,625
|
|
Inventories (1)
|
|
|
|
|
|
|
165,349
|
|
|
|
168,451
|
|
Deferred Tax Assets
|
|
|
|
|
|
|
17,120
|
|
|
|
16,988
|
|
Warrant Receivable (2)
|
|
|
|
|
|
|
42,956
|
|
|
|
-
|
|
Prepayments and Other Current Assets
|
|
|
|
|
|
|
61,401
|
|
|
|
60,884
|
|
|
|
|
|
|
|
|
|
|
633,142
|
|
|
|
678,653
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Property, Plant and Equipment
|
|
|
|
|
|
|
282,848
|
|
|
|
298,449
|
|
Long-Term Marketable Securities
|
|
|
|
|
|
|
41,668
|
|
|
|
51,613
|
|
Intangible and Other Assets
|
|
|
|
|
|
|
196,733
|
|
|
|
206,532
|
|
|
|
|
|
|
|
|
|
$
|
1,154,391
|
|
|
$
|
1,235,247
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
Accounts Payable
|
|
|
|
|
|
|
35,510
|
|
|
|
61,164
|
|
Current Debt (3)
|
|
|
|
|
|
|
124,515
|
|
|
|
122,500
|
|
Accrued Employees' Compensation and Withholdings
|
|
|
|
|
|
|
59,741
|
|
|
|
73,521
|
|
Deferred Revenue and Customer Advances
|
|
|
|
|
|
|
54,689
|
|
|
|
58,030
|
|
Convertible Note Hedge Payable (2)
|
|
|
|
|
|
|
64,616
|
|
|
|
-
|
|
Other Accrued Liabilities
|
|
|
|
|
|
|
44,183
|
|
|
|
51,748
|
|
|
|
|
|
|
|
|
|
|
383,254
|
|
|
|
366,963
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retirement Plans Liabilities
|
|
|
|
|
|
|
132,012
|
|
|
|
125,877
|
|
Deferred Tax Liabilities
|
|
|
|
|
|
|
5,203
|
|
|
|
8,730
|
|
Other Long-Term Liabilities
|
|
|
|
|
|
|
25,547
|
|
|
|
27,565
|
|
Long-Term Debt (3)
|
|
|
|
|
|
|
8,056
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
554,072
|
|
|
|
529,135
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Equity
|
|
|
|
|
|
|
600,319
|
|
|
|
706,112
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,154,391
|
|
|
$
|
1,235,247
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) As of April 5, 2009 and December 31, 2008, Inventories included
approximately $14 million and $15 million, respectively, for Eagle
Test inventory fair value step-up.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) On March 31, 2009, in connection with our convertible note
offering, we entered into convertible note hedge and warrant
transactions. These transactions are expected to reduce the
potential dilution to Teradyne's common stock upon future
conversions of the convertible notes. On April 6, 2009, the
convertible note and convertible note hedge and warrant
transactions closed and we netted approximately $163 million of
cash, before paying off the $122.5 million bank revolver.
Consequently, our cash balance increased by approximately $40
million as a result of these financing transactions.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3) On March 31, 2009, we entered into a loan agreement in Japan
for approximately $10 million. The loan has a term of 5 years and
a fixed interest rate of 1.4%. At April 5, 2009, $2 million of the
outstanding loan principal is included in current debt and $8
million is classified as long-term debt.
|
|
GAAP to Non-GAAP Earnings Reconciliation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References by the Company to non-GAAP (loss)/income and non-GAAP
(loss)/income per share refer to net (loss)/income and net
(loss)/income per common share excluding goodwill impairment,
in-process research and development, restructuring and other, net,
certain inventory provision reversals, fair value inventory step-up
related to Nextest and Eagle Test, losses on marketable securities
and acquired intangible asset amortization, as well as applicable
adjustments to profit sharing and income taxes due to these
exclusions. GAAP requires that these items be included in
determining net (loss)/income. Non-GAAP (loss)/income (which is the
basis for non-GAAP (loss)/income per share) gives an indication of
Teradyne's baseline performance before gains, losses or other
charges that may not be indicative of our current core business or
future outlook.
|
|
|
|
The Company believes these non-GAAP measures will aid investors'
overall understanding of the Company's results by providing a higher
degree of transparency for certain expenses and providing a level of
disclosure that will help investors understand how the Company plans
and measures its own business. However, the presentation of non-GAAP
measures is not meant to be considered in isolation or as a
substitute for, or superior to, financial information provided in
accordance with GAAP.
|
|
|
|
(In millions, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended:
|
|
|
|
|
|
|
|
April 5, 2009
|
|
|
December 31, 2008
|
|
|
March 30, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Revenues
|
|
$
|
120.6
|
|
|
|
$
|
194.8
|
|
|
|
$
|
297.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Margin - GAAP
|
|
$
|
33.4
|
|
|
27.7
|
%
|
$
|
77.9
|
|
|
40.0
|
%
|
$
|
138.5
|
|
|
46.6
|
%
|
|
Inventory step-up reversal (1)
|
|
|
1.2
|
|
|
|
|
0.7
|
|
|
|
|
4.3
|
|
|
|
|
Inventory provision reversal (2)
|
|
|
-
|
|
|
|
|
(1.0
|
)
|
|
|
|
(0.9
|
)
|
|
|
|
Gross Margin - non-GAAP
|
|
$
|
34.6
|
|
|
28.7
|
%
|
$
|
77.6
|
|
|
39.8
|
%
|
$
|
141.9
|
|
|
47.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss)/Income from Operations - GAAP
|
|
$
|
(93.4
|
)
|
|
-77.4
|
%
|
$
|
(383.2
|
)
|
|
-196.7
|
%
|
$
|
1.4
|
|
|
0.5
|
%
|
|
Restructuring and other, net (3)
|
|
|
16.0
|
|
|
|
|
9.7
|
|
|
|
|
11.8
|
|
|
|
|
Acquired intangible asset amortization
|
|
|
8.2
|
|
|
|
|
7.0
|
|
|
|
|
3.9
|
|
|
|
|
Inventory step-up reversal (1)
|
|
|
1.2
|
|
|
|
|
0.7
|
|
|
|
|
4.3
|
|
|
|
|
Goodwill impairment
|
|
|
-
|
|
|
|
|
333.3
|
|
|
|
|
-
|
|
|
|
|
In-process research and development
|
|
|
-
|
|
|
|
|
0.5
|
|
|
|
|
1.1
|
|
|
|
|
Inventory provision reversal (2)
|
|
|
-
|
|
|
|
|
(1.0
|
)
|
|
|
|
(0.9
|
)
|
|
|
|
Profit sharing adjustment (6)
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
(0.8
|
)
|
|
|
|
(Loss)/Income from Operations - non-GAAP
|
|
$
|
(68.0
|
)
|
|
-56.4
|
%
|
$
|
(33.0
|
)
|
|
-16.9
|
%
|
$
|
20.8
|
|
|
7.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (Loss)/Income - GAAP
|
|
$
|
(90.7
|
)
|
|
-75.2
|
%
|
$
|
(388.6
|
)
|
|
-199.5
|
%
|
$
|
2.4
|
|
|
0.8
|
%
|
|
Restructuring and other, net (3)
|
|
|
16.0
|
|
|
|
|
9.7
|
|
|
|
|
11.8
|
|
|
|
|
Acquired intangible asset amortization
|
|
|
8.2
|
|
|
|
|
7.0
|
|
|
|
|
3.9
|
|
|
|
|
Interest and other (4)
|
|
|
2.6
|
|
|
|
|
5.9
|
|
|
|
|
-
|
|
|
|
|
Inventory step-up reversal (1)
|
|
|
1.2
|
|
|
|
|
0.7
|
|
|
|
|
4.3
|
|
|
|
|
Income tax adjustment (5)
|
|
|
(2.9
|
)
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
Goodwill impairment
|
|
|
-
|
|
|
|
|
333.3
|
|
|
|
|
-
|
|
|
|
|
In-process research and development
|
|
|
-
|
|
|
|
|
0.5
|
|
|
|
|
1.1
|
|
|
|
|
Inventory provision reversal (2)
|
|
|
-
|
|
|
|
|
(1.0
|
)
|
|
|
|
(0.9
|
)
|
|
|
|
Profit sharing adjustment (6)
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
(0.8
|
)
|
|
|
|
Net (Loss)/Income - non-GAAP
|
|
$
|
(65.6
|
)
|
|
-54.4
|
%
|
$
|
(32.5
|
)
|
|
-16.7
|
%
|
$
|
21.8
|
|
|
7.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP Net (Loss)/Income per Common Share - Basic
|
|
|
(0.53
|
)
|
|
|
|
(2.30
|
)
|
|
|
|
0.01
|
|
|
|
|
Non-GAAP Net (Loss)/Income per Common Share - Basic
|
|
|
(0.38
|
)
|
|
|
|
(0.19
|
)
|
|
|
|
0.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP and Non-GAAP Weighted Average Common Shares - Basic
|
|
|
172.1
|
|
|
|
|
169.2
|
|
|
|
|
173.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP Net (Loss)/ Income per Common Share - Diluted
|
|
|
(0.53
|
)
|
|
|
|
(2.30
|
)
|
|
|
|
0.01
|
|
|
|
|
Non-GAAP Net (Loss)/Income per Common Share - Diluted
|
|
|
(0.38
|
)
|
|
|
|
(0.19
|
)
|
|
|
|
0.12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP and Non-GAAP Weighted Average Common Shares - Diluted
|
|
|
172.1
|
|
|
|
|
169.2
|
|
|
|
|
175.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Reversal of Nextest and Eagle Test purchase accounting inventory
step-up.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) Reversal of previously written down inventory for non-FLEX
products in the Semiconductor Test Division.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3) Restructuring and other, net consists of (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April 5, 2009
|
|
|
December 31, 2008
|
|
|
March 30, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee Severance
|
|
$
|
16.7
|
|
|
|
$
|
8.9
|
|
|
|
$
|
7.1
|
|
|
|
|
Eagle Test Purchase Accounting Adjustment
|
|
|
(0.7
|
)
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
Acquisition Financing Costs
|
|
|
-
|
|
|
|
|
0.8
|
|
|
|
|
-
|
|
|
|
|
Facility Related
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
4.7
|
|
|
|
|
|
|
|
|
$
|
16.0
|
|
|
|
$
|
9.7
|
|
|
|
$
|
11.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4) For the quarter ended April 5, 2009, Interest and Other included
other-than-temporary impairment and realized losses on marketable
securities. For the quarter ended December 31, 2008, Interest and
Other included other-than-temporary impairment and realized losses
on marketable securities and reversal of the charge for acquisition
financing costs.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5) Income tax adjustment for foreign exchange item.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6) Profit sharing adjustment for non-GAAP items.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For press releases and other information of interest to investors,
please visit Teradyne's homepage on the World Wide Web at http://www.teradyne.com.
|
